1. Home
  2. ASTE vs ORIC Comparison

ASTE vs ORIC Comparison

Compare ASTE & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTE
  • ORIC
  • Stock Information
  • Founded
  • ASTE 1972
  • ORIC 2014
  • Country
  • ASTE United States
  • ORIC United States
  • Employees
  • ASTE N/A
  • ORIC N/A
  • Industry
  • ASTE Construction/Ag Equipment/Trucks
  • ORIC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTE Industrials
  • ORIC Health Care
  • Exchange
  • ASTE Nasdaq
  • ORIC Nasdaq
  • Market Cap
  • ASTE 915.1M
  • ORIC 940.8M
  • IPO Year
  • ASTE N/A
  • ORIC 2020
  • Fundamental
  • Price
  • ASTE $37.91
  • ORIC $10.12
  • Analyst Decision
  • ASTE Hold
  • ORIC Strong Buy
  • Analyst Count
  • ASTE 1
  • ORIC 9
  • Target Price
  • ASTE $41.00
  • ORIC $18.29
  • AVG Volume (30 Days)
  • ASTE 163.5K
  • ORIC 1.2M
  • Earning Date
  • ASTE 08-06-2025
  • ORIC 08-11-2025
  • Dividend Yield
  • ASTE 1.37%
  • ORIC N/A
  • EPS Growth
  • ASTE N/A
  • ORIC N/A
  • EPS
  • ASTE 0.66
  • ORIC N/A
  • Revenue
  • ASTE $1,325,300,000.00
  • ORIC N/A
  • Revenue This Year
  • ASTE $5.43
  • ORIC N/A
  • Revenue Next Year
  • ASTE $4.22
  • ORIC N/A
  • P/E Ratio
  • ASTE $57.23
  • ORIC N/A
  • Revenue Growth
  • ASTE 1.99
  • ORIC N/A
  • 52 Week Low
  • ASTE $29.04
  • ORIC $3.90
  • 52 Week High
  • ASTE $43.35
  • ORIC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • ASTE 38.53
  • ORIC 43.96
  • Support Level
  • ASTE $38.99
  • ORIC $10.00
  • Resistance Level
  • ASTE $41.05
  • ORIC $11.62
  • Average True Range (ATR)
  • ASTE 1.11
  • ORIC 0.63
  • MACD
  • ASTE -0.09
  • ORIC -0.24
  • Stochastic Oscillator
  • ASTE 2.79
  • ORIC 20.68

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: